Dr. Brian Christopher Cambi, MD

Dr. Cambi practices at Yale Medicine in New Haven, Connecticut.

Dr. Cambi's NPI, 1003033390, was assigned on April 19, 2007. Dr. Cambi graduated from State University of New York at Buffalo School of Medicine in 1999. Dr. Cambi holds Connecticut license 040303.

Dr. Cambi's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Cambi's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Cambi is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Cambi to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cambi practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Cambi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Cambi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Cambi is licensed in Connecticut.

CMS data shows 1,113 Medicare services from Dr. Cambi across 12 procedure codes in 2024, for 451 Medicare patients. Medicare paid $77,339 for them.

CMS counts 451 Medicare patients who saw Dr. Cambi in 2024. The largest group is 75 to 84, with 217 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cambi's median patient age at 76, with 43% women.

In 2024, Dr. Cambi wrote 2,228 Medicare Part D claims for 481 patients. 88% of them were for generic drugs. CMS names the drug for 2,049 of them, across 32 drugs with 11 or more claims each, at $340,866 in total drug cost. In 2023, CMS named 2,685 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Cambi for performance year 2024, reported through an alternative payment model (APM). Dr. Cambi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of coronary angioplasty and stenting by Dr. Cambi, more than 67% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Cambi, published from 2021 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Colchicine, COVID-19 and SARS-CoV-2. Dr. Cambi's most frequent co-authors are Rami Ahmad, MD, Michael W. Cleman, MD and Nitu M. Kashyap, MD.

Dmand AI links Dr. Cambi to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 28 general payments to Dr. Cambi from 10 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $790.

Dr. Cambi graduated from State University of New York at Buffalo School of Medicine in 1999.